Please assess the completion status of the following clinical trial:

Trial Title: Novel MRI Strategies as a Non-invasive Biomarker in Women With Uterine Fibroids

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion criteria:~* Age\>18 years~* Scheduled for hysterectomy with a fibroid uterus~* At least one intramural non-pedunculated, submucosal or subserous fibroid(\>2cm) or multiple small fibroids (uterine volume\>200cm3)~* Ability to understand and willingness to sign consent form~* Normal smear within 3 years~Exclusion criteria:~* Pregnant or lactating~* Contra indication to MRI~* Unable to tolerate supine position~* Diabetes and/or renal or hepatic impairment~* Contra indication to any of the study medications including gadolinium, MRI contrast

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): GnRH analogue-Zoladex
- 2 (Type: ACTIVE_COMPARATOR): GnRH antagonist plus GnRH analogue
- 3 (Type: NO_INTERVENTION): None

Based on this trial design, predict the completion outcome and termination type (if applicable).